Oxygenation in medetomidine-sedated dogs with and without 100% oxygen insufflation

Veterinary Therapeutics

Volumn 8, Issue 1, 2007, Pages 51-60

  Ko, Jeff C H ^a   Weil, Ann B ^a   Kitao, Takashi ^b   Payton, Mark E ^b   Inoue, Tomohito ^a  

^a PURDUE UNIVERSITY   (United States)

^b 301 MSCS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT; MEDETOMIDINE; OXYGEN;

ANESTHESIA; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD GAS ANALYSIS; BREATHING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; OXYGEN THERAPY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASOCONSTRICTION;

ADRENERGIC ALPHA-AGONISTS; ANESTHESIA; ANIMALS; BLOOD GAS ANALYSIS; DOGS; FEMALE; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; MALE; MEDETOMIDINE; OXYGEN; OXYGEN INHALATION THERAPY; RESPIRATION; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 34249659507     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Sinclair MD: A review of the physiological effects of α2-agonists related to the clinical use of medetomidine in small animal practice. Can Vet J 44:885-897, 2003.
2. Kuo WC, Keegan RD: Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs. Am J Vet Res 65(7):931-937, 2004.
3. England GCW, Clarke KW: The effect of route of administration upon the efficacy of medetomidine. J Assoc Vet Anaesth 16:32-34, 1989.
4. Clarke KW, England GCW: Medetomidine, a new sedative-analgesia for use in the dog and its reversal with atipamezole. J Small Anim Pract 30:343-348, 1989.
5. Vaha-Vahe AT: Clinical evaluation of mederomidine, a novel sedative and analgesic drug for dogs and cats. Acta Vet Scand 30:267-273, 1989.
6. Martin L: PaO2, SaO2 and oxygen content, in Martin L (ed): All You Really Need to Know to Interpret Arterial Blood Gases. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 68-82.
7. Ko JC, Bailey JE, Pablo LS, Heaton-Jones TG: Comparison of sedative and cardiorespiratory effects of medetomidine and medetomidine-butorphanol combination in dogs. Am J Vet Res 57:535-540, 1996.
8. Ko JC, Fox SM, Mandsager RE: Sedative and cardiorespiratory effects of mederomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. JAVMA 216:1578-1583, 2000.
9. Oeseburg B, Rolfe P, Siggaard Andersen O, et al: Definition and measurement of quantities pertaining to oxygen in blood, in Vasupel V (ed): Oxygen Transport to Tissue XV. New York, Plenum Press, 1994, pp 925-930.
10. Helfaer MA, Nichols DG, Rogers MC: Developmental physiology of the respiratory system, in Rogers MC (ed): Textbook of Pediatric Intensive Care. Baltimore, Williams & Wilkins, 1996, pp 97-126.
11. Karagiannis MH, Reniker AN, Keral ME, Mann FA: Lactate measurement as an indicator of perfusion. Compend Contin Educ Prac Vet 28:287-300, 2006.
12. Vainio O, Vaha-Vahe T, Palmu L: Sedative and analgesic effect of mederomidine in dogs. J Vet Pharmacol Ther 12:225-231, 1989.
13. Simon E Romvary A, Mora S: Clinical investigations of medetomidine in dogs. Acta Vet Scand 85:161-165, 1989.
14. Vaha-Vahe T: The clinical efficacy of medetomidine. Acta Vet Scand 85:155-153, 1989.
15. Nilsfors L, Garmer L, Adolfsson A: Sedative and analgesic effects of medetomidine in dogs - An open clinical study. Acta Vet Scand Suppl 85:155-159, 1989.
16. Pettifer GR, Dyson DH: Comparison of medetomidine and fentanyl-droperidol in dogs: Sedation, analgesia, arterial blood gases and lactate levels. Can J Vet Res 57:99-105, 1993.